Clinical Trial Update: A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria [Phase 1]

View source ↗

Summary

A Phase 1 study of GTX-B001 in healthy subjects and individuals with chronic inducible urticaria is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cold Urticaria
• Dermatographic Urticaria
• Inducible Urticaria

Drugs mentioned

• GTX-B001

Snippet

Sponsor: Granular Therapeutics Limited | Conditions: Healthy Subjects, Cold Urticaria | Phase 1 | Status: RECRUITING